Methyl 2-amino-4-bromo-3,6-difluorobenzoate, 100mg

4-Cyano-3-fluorophenyl 4-(trans-4-pentylcyclohexyl)benzoate, 97%, 10g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylic acid, 95.0%, 5g

6-Oxopiperidine-3-carboxylic acid, 95.0%, 1g

4-Bromo-1,3-dimethyl-1H-pyrazole, 95.0%, 25g

Ethyl 6-Bromo-4 - ((3- (Trifluoromethyl) Phenyl) Amino) Quinoline-3-Carboxylate, 97%, 100mg

7-HYDROXYSPIRO[CHROMAN-2,4'-PIPERIDIN]-4-ONE HCL, 95.0%, 1g

Ethyl 4-chloro-5,8-dimethylquinoline-3-carboxylate, 95.0%, 1g

Pyrazolo[3,4-b]pyridine>98.0%(HPLC)(T)200mg

2-(4,4-difluoropiperidin-1-yl)ethan-1-ol, 95.0%, 1g

Matraz receptor con revestimiento de PUR, 100 ml, 1 unidad

2-Phenylbenzo[d]oxazole, 98.0%, 10g

Methyl 2-(piperidin-1-ylmethyl)benzoate, 95.0%, 1g